Postdoctoral training in Pediatric Clinical Pharmacology

 描述(由申请者提供)：这一新的儿科临床药理学博士后研究培训计划是国家儿童医学中心儿科临床药理学奖学金计划的自然增强。与FDA临床药理学办公室和约翰霍普金斯大学医学院的T32临床药理学培训计划的现有合作将得到加强，而与马里兰大学药学院T32培训计划的新合作将启动，以进一步扩大儿童和成人临床药理学学科的受训人员的机会。拥有医学博士、药学博士和/或博士学位的受训者将进入这个为期两年的项目，该项目主要设在华盛顿特区的儿童国家医学中心(CNMC)儿童研究所。该项目的重点将是鼓励有前途的年轻研究人员参与，他们将把精力集中在儿科临床药理学领域基础、翻译和/或临床研究的方法和实际开展方面的培训和经验上，以便为他们提供所有必要的工具，使他们成为这一重要学科的独立研究人员，并成为儿科临床药理学未来的领导者。培训的一个独特方面是，基础、翻译和临床方面将被视为“团队科学”。我们预计将培训8名非常有干劲的年轻研究人员(4名医学博士、2名药学博士和2名博士)。每一位学员将通过该计划得到仔细的指导，以确保他/她充分利用该计划的一系列机会。

 DESCRIPTION (provided by applicant): This new postdoctoral research training program in Pediatric Clinical Pharmacology is a natural enhancement of the Pediatric Clinical Pharmacology fellowship program at Children's National Medical Center. The already existing collaboration with the Office of Clinical Pharmacology at the FDA and the T32 training program in Clinical Pharmacology at Johns Hopkins University School of Medicine will be intensified, whereas a new collaboration with the T32 training program at the University of Maryland School of Pharmacy will be initiated to even further broaden the opportunities of trainees in the discipline of Pediatric and Adult Clinical Pharmacology. Trainees with a M.D., Pharm.D., and/or Ph.D. will enter the two-year program that is primarily housed at the Children's Research Institute of Children's National Medical Center (CNMC) in Washington, D.C. The focus of this program will be to encourage the involvement of promising young researchers who will focus their efforts on training and experience in the methods and actual conduct of basic, translational and/or clinical research in the area of Pediatric Clinical Pharmacology in order to provide them with all the necessary tools to become independent researchers in this important discipline and to become future leaders in Pediatric Clinical Pharmacology. A unique aspect of the training will be that basic, translational and clinical aspects will be approached as "team science". We expect to train 8 young very motivated researchers (4 MDs, 2 PharmDs and 2 PhDs). Each trainee will be carefully mentored through the program to ensure that he/she fully exploits the range of opportunities of the program.